|

HF158K1 /Arm 45 mg/m² Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Infusion

Pipeline

Phase 1: 1

Top Sponsors

  • HighField Biopharmaceuticals Corporation1

Indications

  • Solid Tumors, Adult1
  • Cancer1

Dallas, Texas1 trial

A Clinical Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HF158K1 in Participants With HER-2 Positive or HER-2 Low Expression Advanced Solid Tumors

Mary Crowley Cancer Research

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.